Interferon-induced thyroid dysfunction - Not always transient

Journal of Gastroenterology and Hepatology (Australia)

Volumn 24, Issue 6, 2009, Pages 938-940

  Wong, Vincent Wai Sun ^b   Cheng, Angela Yuen Shan ^c   Chan, Henry Lik Yuen ^a,b  

^a CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^b CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

^c St Teresa's Hospital   (Hong Kong)

Author keywords

[No Author keywords available]

Indexed keywords

GAMMA INTERFERON INDUCIBLE PROTEIN 10; INTERFERON; LAMIVUDINE; PEGINTERFERON; PEGINTERFERON ALPHA; RIBAVIRIN; THYROID ANTIBODY; THYROID PEROXIDASE ANTIBODY; THYROTROPIN; THYROXINE; VIRUS RNA;

ANTIBODY PRODUCING CELL; ANTIVIRAL THERAPY; ASPIRATION BIOPSY; B LYMPHOCYTE; CAUSAL ATTRIBUTION; CELL EXPANSION; CHIMPANZEE; CYTOLOGY; DRUG WITHDRAWAL; EDITORIAL; HEPATITIS B; HEPATITIS C; HORMONE SUBSTITUTION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; IMMUNOMODULATION; KIDNEY DISEASE; LYMPHOCYTIC THYROIDITIS; LYMPHOPROLIFERATIVE DISEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PATHOGENESIS; PATIENT MONITORING; PERIPHERAL BLOOD MONONUCLEAR CELL; PRIORITY JOURNAL; SIDE EFFECT; THYROID CANCER; THYROID DISEASE; THYROID FUNCTION TEST; THYROTROPIN BLOOD LEVEL; TREATMENT DURATION;

ANIMALS; ANTIVIRAL AGENTS; DRUG THERAPY, COMBINATION; HEPATITIS C, CHRONIC; HUMANS; INTERFERON ALFA-2A; POLYETHYLENE GLYCOLS; RIBAVIRIN; RISK FACTORS; THYROID DISEASES; TIME FACTORS;

EID: 66549100931     PISSN: 08159319     EISSN: 14401746     Source Type: Journal    
DOI: 10.1111/j.1440-1746.2009.05853.x     Document Type: Editorial

References (17)

1. Sansonno D, Carbone A, De Re V, Dammacco F. Hepatitis c virus infection, cryoglobulinaemia, and beyond. Rheumatology (Oxford) 2007 46 : 572 8.
2. Antonelli A, Ferri C, Pampana A et al. Thyroid disorders in chronic hepatitis C. Am. J. Med. 2004 117 : 10 13. (Pubitemid 38798015)
3. Ferri C, Monti M, La Civita L et al. Infection of peripheral blood mononuclear cells by hepatitis C virus in mixed cryoglobulinemia. Blood 1993 82 : 3701 4.
4. Kee KM, Lee CM, Wang JH et al. Thyroid dysfunction in patients with chronic hepatitis C receiving a combined therapy of interferon and ribavirin: incidence, associated factors and prognosis. J. Gastroenterol. Hepatol. 2006 21 : 319 26.
5. Tran HA, Attia JR, Jones TL, Batey RG. Pegylated interferon-alpha2beta in combination with ribavirin does not aggravate thyroid dysfunction in comparison to regular interferon-alpha2beta in a hepatitis C population: meta-analysis. J. Gastroenterol. Hepatol. 2007 22 : 472 6.
6. Marcellin P, Pouteau M, Renard P et al. Sustained hypothyroidism induced by recombinant alpha interferon in patients with chronic hepatitis C. Gut 1992 33 : 855 6.
7. Vezali E, Elefsiniotis I, Mihas C, Konstantinou E, Saroglou G. Thyroid dysfunction in patients with chronic hepatitis C: Virus- or therapy-related? J. Gastroenterol. Hepatol. 2009 24 : 1024 9.
8. Chan HL, Leung NW, Hui AY et al. A randomized, controlled trial of combination therapy for chronic hepatitis B: comparing pegylated interferon-alpha2b and lamivudine with lamivudine alone. Ann. Intern. Med. 2005 142 : 240 50.
9. Chan HL, Wong VW, Chim AM et al. Virological response to different combination regimes of peginterferon alpha-2b and lamivudine in hepatitis B e antigen positive chronic hepatitis B. Antivir. Ther. 2007 12 : 815 23.
10. Jamil KM, Leedman PJ, Kontorinis N et al. Interferon-induced thyroid dysfunction in chronic hepatitis C. J. Gastroenterol. Hepatol. 2009 24 : 1017 23.
11. Lee SD, Yu ML, Cheng PN et al. Comparison of a 6-month course peginterferon alpha-2b plus ribavirin and interferon alpha-2b plus ribavirin in treating Chinese patients with chronic hepatitis C in Taiwan. J. Viral Hepat. 2005 12 : 283 91.
12. Carella C, Mazziotti G, Amato G, Braverman LE, Roti E. Clinical review 169: Interferon-alpha-related thyroid disease: pathophysiological, epidemiological, and clinical aspects. J. Clin. Endocrinol. Metab. 2004 89 : 3656 61.
13. Prummel MF, Laurberg P. Interferon-alpha and autoimmune thyroid disease. Thyroid 2003 13 : 547 51.
14. Antonelli A, Ferri C, Fallahi P, Nesti C, Zignego AL, Maccheroni M. Thyroid cancer in HCV-related mixed cryoglobulinemia patients. Clin. Exp. Rheumatol. 2002 20 : 693 6.
15. Friedrich-Rust M, Theobald J, Zeuzem S, Bojunga J. Thyroid function and changes in ultrasound morphology during antiviral therapy with pegylated interferon and ribavirin in patients with chronic hepatitis C. J. Viral Hepat. 2009 16 : 168 77.
16. Bartolome J, Rodriguez-Inigo E, Quadros P et al. Detection of hepatitis C virus in thyroid tissue from patients with chronic HCV infection. J. Med. Virol. 2008 80 : 1588 94.
17. Rotondi M, Minelli R, Magri F et al. Serum CXCL10 levels and occurrence of thyroid dysfunction in patients treated with interferon-alpha therapy for hepatitis C virus-related hepatitis. Eur. J. Endocrinol. 2007 156 : 409 14.